Investi Stratix
  • Politics
  • Economy
  • Forex
  • Stock
  • Editor’s Pick
  • Politics
  • Economy
  • Forex
  • Stock
  • Editor’s Pick
No Result
View All Result
Investi Stratix
No Result
View All Result

US imposing new export controls on biotech equipment over China concerns

by
January 15, 2025
in Stock
0
US imposing new export controls on biotech equipment over China concerns

By David Shepardson

WASHINGTON (Reuters) – The U.S. Commerce Department said Wednesday it is imposing new export controls on biotechnology equipment and related technology because of national security concerns tied to artificial intelligence and data science.

Washington has raised concerns that China could use U.S. technology to strengthen military capabilities and help design new weapons through AI. The department said the laboratory equipment could be used for “human performance enhancement, brain-machine interfaces, biologically-inspired synthetic materials, and possibly biological weapons.”

The new export controls, which restrict shipments to China and other countries without a U.S. license, are for high-parameter flow cytometers and certain mass spectrometry equipment, which Commerce said can “generate high-quality, high-content biological data, including that which is suitable for use to facilitate the development of AI and biological design tools.”

This is the latest effort by Washington to restrict U.S. technology to China. On Monday, Commerce moved to further restrict AI chip and technology exports from China aimed at helping the United States maintain its dominant status in AI by controlling it around the world.

U.S. lawmakers have been considering a number of proposals to keep Americans’ personal health and genetic information from foreign adversaries and aim to push U.S. pharmaceutical and biotech companies to lessen their reliance on China for everything from drug ingredient manufacturing to early research.

Last week, U.S. lawmakers called on the Commerce Department to consider restricting the export of U.S. biotechnology to the Chinese military, citing concerns Beijing could weaponize it.

The Chinese Embassy in Washington last week said Beijing “firmly opposes any country’s development, possession or use of biological weapons.”

In August, U.S. lawmakers called on the Food and Drug Administration to ramp up scrutiny of U.S. clinical trials conducted in China, citing the risk of intellectual property theft and the possibility of forced participation of members of China’s Uyghur minority group.

This post appeared first on investing.com
Previous Post

Trump’s new SEC leadership poised to kick start crypto overhaul, sources say

Next Post

US health officials set to ban Red No. 3 food coloring- Bloomberg News

Next Post
US health officials set to ban Red No. 3 food coloring- Bloomberg News

US health officials set to ban Red No. 3 food coloring- Bloomberg News

Subscribe to InvestiStratix.com

    Popular News

    ECB flags tariff risks as key threat to Eurozone banks in supervisory push

    ECB flags tariff risks as key threat to Eurozone banks in supervisory push

    July 16, 2025
    UBS predicts further slowing of US economic growth in second half of 2025

    UBS predicts further slowing of US economic growth in second half of 2025

    July 16, 2025
    How billionaire Caltagirone could influence Italy’s banking M&A wave

    How billionaire Caltagirone could influence Italy’s banking M&A wave

    July 16, 2025
    Coinbase faces weak Q2 outlook, but long-term prospects intact, says Oppenheimer

    Coinbase faces weak Q2 outlook, but long-term prospects intact, says Oppenheimer

    July 15, 2025
    OpenAI, Google, Musk’s xAI wins US Pentagon contracts

    OpenAI, Google, Musk’s xAI wins US Pentagon contracts

    July 15, 2025

    Trending News

    ECB flags tariff risks as key threat to Eurozone banks in supervisory push

    ECB flags tariff risks as key threat to Eurozone banks in supervisory push

    July 16, 2025
    UBS predicts further slowing of US economic growth in second half of 2025

    UBS predicts further slowing of US economic growth in second half of 2025

    July 16, 2025

    Popular News

    • How billionaire Caltagirone could influence Italy’s banking M&A wave
      July 16, 2025
    • How billionaire Caltagirone could influence Italy’s banking M&A wave
      July 15, 2025

    About Us

    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 investistratix.com | All Rights Reserved

    No Result
    View All Result
    • Politics
    • Economy
    • Forex
    • Stock
    • Editor’s Pick

    Copyright © 2025 investistratix.com | All Rights Reserved